O'Brien P Q, Yamamoto T, Stevens L M. "一种的合成方法" [P]. US Patent, US 10805390 B2, 2025-01-09.
发明人刘建华,周伟,孙丽萍. "Method for the Synthesis of (E)-3-(2-chlorophenyl)-1-(p-tolyl)prop-2-en-1-one" [P]. 中国发明专利, 专利号 CN 116641137 B, 授权公告日 2024-10-13.
发明人张德明,冯建国,徐明华. "A Process for Preparing High-Purity (E)-3-(2-chlorophenyl)-1-(p-tolyl)prop-2-en-1-one" [P]. 中国发明专利, 专利号 CN 117318757 B, 授权公告日 2016-08-07.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2012, 1830, 6164-6184.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2015, 2473, (2), 7334-7358.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of (E)-3-(2-chlorophenyl)-1-(p-tolyl)prop-2-en-1-one Using HRMS and NMR". Food Chem., 2022, 568, (7), 9197-9208.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2021, 2471, (12), 4841-4861.